Vaccine News and Research

Latest Vaccine News and Research

New advance in healthcare collaboration between CII and USIBC announced

The Confederation of Indian Industry and the U.S.-India Business Council today announced a major new advance in healthcare collaboration, partnering under the banner of the USIBC-led “Coalition for Healthy India”.

6 Nov 2009

Physicians concern about the spread of H1N1 virus and the availability of H1N1 vaccine

According to a Panel Intelligence survey of 50 primary care physicians, there are significant concerns about the H1N1 virus not just in terms of disease prevalence and vaccine shortages, but also in that 38% of the physicians surveyed (PCPs, pediatricians, and gerontologists) are "very concerned" about the virus evolving into a more serious strain and another 52% have moderate concerns about such a development.

6 Nov 2009

Alliance Québécoise du Psoriasis provides information concerning H1N1 vaccination campaign

The Alliance Québécoise du Psoriasis (Quebec psoriasis alliance) would like to give its members and other psoriasis sufferers information concerning the massive H1N1 vaccination campaign.

6 Nov 2009

Unum enhances the wellness benefit of its critical illness products by adding H1N1 vaccine

Unum has enhanced the wellness benefit of its critical illness products by adding the H1N1 vaccine to the list of qualifying procedures.

6 Nov 2009

Walls Street journal examines big pharma's 'growing interest' in emerging-market vaccine development, production

The Wall Street Journal examines "big pharma's growing interest in a corner of healthcare - emerging-market inoculations," in light of a recent move by Novartis to purchase an 85 percent stake in the Chinese vaccine maker Zhejiang Tianyuan Bio-Pharmaceutical Co. In the summer, drug maker Sanofi-Aventis SA made a similar move to acquire a majority stake in India's Shantha Biotechnics, the newspaper notes.

6 Nov 2009

HHS announces contract awards for up to 120,000 treatment courses of intravenous antiviral drugs

The U.S. Department of Health and Human Services (HHS) today announced contract awards for up to 120,000 treatment courses of intravenous (IV) antiviral drugs to help treat hospitalized 2009 H1N1 influenza patients.

6 Nov 2009

Malaria experts discuss eradication at MIM conference

In a session at the 5th Multilateral Initiative on Malaria (MIM) Pan-African Conference in Nairobi, Kenya, experts discussed the tools required to eradicate the disease and highlighted insecticide and drug resistance in some parts of the world, Xinhua reports. Researchers noted that resistance to artemisinin-based combination therapies (ACTs) has been documented in western Cambodia and "has now also been reported in the west of Thailand and in eastern Myanmar," the news service writes (Ooko/Zhuoyun, 11/5).

6 Nov 2009

GenVec and SAIC-Frederick signs contract to develop influenza and HIV vaccines

GenVec, Inc, announced today that SAIC-Frederick, Inc. has signed a contract with GenVec for the development of influenza and HIV vaccines in support of the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).

5 Nov 2009

U.S. health officials offer no prediction of when all high-risk groups will have access to H1N1 vaccine

U.S. health officials briefing Congress on Wednesday would not outline a timeline for when enough H1N1 (swine flu) vaccines would be available to reach all high-risk populations in the country, the Washington Post reports.

5 Nov 2009

Also in global health news: Kenya child mortality; DRC rape; Cape Verde dengue outbreak; Guatemala malnutrition; East Africa flooding

"The most current data from the Kenya National Bureau of Statistics under the Demographic and Health Survey (DHS) launched on Wednesday shows mortality among children under five years stands at 7.4 percent, while that of infants is at 5.2 percent," Business Daily reports.

5 Nov 2009

New biosensor device may help in combating cancer

A powerful new biosensor developed by European researchers will help identify cells in the immune system that actively suppress tumour growth, then put them to use. Enlisting the patient's own immune system would be like sending reinforcements for resistance fighters.

5 Nov 2009

Idera Pharmaceuticals announces financial results for the third quarter of 2009

Idera Pharmaceuticals, Inc. today reported financial results for the third quarter and nine months ended September 30, 2009.

5 Nov 2009

Phadia offers ImmunoCAP, a reliable test to accurately diagnose the severity of egg allergy

The World Health Organization recently declared H1N1 swine flu a global pandemic, resulting in the creation of rigorous vaccination programs worldwide. Children are among those considered particularly susceptible to contracting swine flu and are viewed as a top priority in receiving this vaccine.

5 Nov 2009

Online self-assessment tool on MayoClinic.com helps assess flu symptoms

The flu symptoms self-assessment tool on MayoClinic.com helps you assess whether you or your loved ones have some form of flu, or just a cold. If you possibly or likely have the flu, you'll also learn whether antiviral medication is an option. And you can check a concise list of high-risk groups who should seek medical attention for the flu.

5 Nov 2009

NIAID funds CCHI and IMVC programs to help identify new vaccines for emerging infectious diseases

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded approximately $208 million to two programs that support research to better understand the human immune response to emerging and re-emerging infectious diseases, including those that may be introduced into a community through acts of bioterrorism.

5 Nov 2009

New Merck set to begin global health care operations

Merck & Co., Inc. today outlined its global plans following the completion of Merck's merger with Schering-Plough Corporation announced yesterday. The new Merck is a global health care leader aimed at providing innovative, distinctive products and services that save and improve lives, while satisfying customer needs and creating long term shareholder value.

5 Nov 2009

Symposium on H1N1 and seasonal flu

With the looming threat of both the H1N1 flu (also known as "swine flu") and the regular seasonal flu, area health officials fear that the worst may be in store this coming flu season.

5 Nov 2009

Department of Health urges healthcare professionals to be vaccinated against H1N1 flu

Saying healthcare workers are "on the front lines" of battling the H1N1 flu pandemic, the Department of Health today urged healthcare professionals across Pennsylvania to be vaccinated against the H1N1 flu.

4 Nov 2009

Also in Global Health News: Childhood vaccines; USAID administrator; Pakistan polio fight; UNICEF fundraising; measles in India

As a follow-up to the release of the State of the World's Vaccines and Immunization by the WHO, UNICEF and World Bank last month, The International examines the findings that "despite child vaccinations hitting a record-high with about 106 million infants being immunised this year, life-saving vaccines fail to reach some 24 million children in 72 of the world's poorest countries," many of whom, "are estimated to be most at risk from vaccine-preventable diseases," the publication writes.

4 Nov 2009

News outlets examine international efforts to contain H1N1

A WHO official on Tuesday backed the Afghan government's decision to declare H1N1 (swine flu) a health emergency, forcing the closure of all schools in the country for three weeks in an effort to contain the virus, IRIN reports.

4 Nov 2009

Vaccine News and Research

Latest Vaccine News and Research

New advance in healthcare collaboration between CII and USIBC announced

Physicians concern about the spread of H1N1 virus and the availability of H1N1 vaccine

Alliance Québécoise du Psoriasis provides information concerning H1N1 vaccination campaign

Unum enhances the wellness benefit of its critical illness products by adding H1N1 vaccine

Walls Street journal examines big pharma's 'growing interest' in emerging-market vaccine development, production

HHS announces contract awards for up to 120,000 treatment courses of intravenous antiviral drugs

Malaria experts discuss eradication at MIM conference

GenVec and SAIC-Frederick signs contract to develop influenza and HIV vaccines

U.S. health officials offer no prediction of when all high-risk groups will have access to H1N1 vaccine

Also in global health news: Kenya child mortality; DRC rape; Cape Verde dengue outbreak; Guatemala malnutrition; East Africa flooding

New biosensor device may help in combating cancer

Idera Pharmaceuticals announces financial results for the third quarter of 2009

Phadia offers ImmunoCAP, a reliable test to accurately diagnose the severity of egg allergy

Online self-assessment tool on MayoClinic.com helps assess flu symptoms

NIAID funds CCHI and IMVC programs to help identify new vaccines for emerging infectious diseases

New Merck set to begin global health care operations

Symposium on H1N1 and seasonal flu

Department of Health urges healthcare professionals to be vaccinated against H1N1 flu

Also in Global Health News: Childhood vaccines; USAID administrator; Pakistan polio fight; UNICEF fundraising; measles in India

News outlets examine international efforts to contain H1N1

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Vaccine News and Research

Latest Vaccine News and Research

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in